ILC-UK and IFA issue joint statement on proposed childhood pneumococcal vaccine changes
As organisations concerned with the current and future wellbeing of our rapidly ageing society, the International Longevity Centre – UK (ILC-UK) and the International Federation on Ageing (IFA) have conducted a great deal of work on the burden of pneumococcal disease across the life-course.
We believe that the UK’s immunisation programme over recent years has been very successful in reducing incidences of Invasive Pneumococcal Disease (IPD), a major cause of death globally.
However, in October 2017 the Joint Committee on Vaccination and Immunisation (JCVI) suggested that the childhood vaccination for pneumococcal disease should move from a 2+1 schedule (two initial doses and a follow-up dose) to a 1+1 schedule (one initial dose and a follow-up).
We were concerned to hear from the JCVI’s reports that “moving to a 1+1 schedule might increase IPD cases in infants because of loss of direct protection, and in older adults because of a reduction in herd immunity as a result of less protection against carriage in infants after a single dose.”
We would welcome more detailed research into the potential increase in cases of invasive pneumococcal disease in children and adults that might occur from a change to the pneumococcal immunisation programme, to a ‘1 + 1’ schedule.
Given the potential risks of this decision, we would urge a fuller consultation on proposed changes to the pneumococcal immunisation programme. Perhaps an expert sub-committee of JCVI could be convened to review the evidence before a final decision is made.
Finally, to declare an interest, ILC-UK’s work on immunisation has been financially supported (through non-restricted educational grants) by a range of pharmaceutical companies who may have an interest in this area including SPMSD, Eli Lilly, and Pfizer and the IFA’s work on immunisation has been supported similarly by Pfizer and GSK through unrestricted educational grants.
David Sinclair Jane Barratt
Director Secretary General
ILC-UK International Federation on Ageing
Date :28 January 2018
The International Longevity Centre – UK (ILC-UK) and Just Group have analysed the submissions and created a shortlist to take forward that helps deal with ageing issues such as cognitive decline, failing physical health, loneliness and digital exclusion.
Date :12 June 2018
Recruitment - ILC-UK are recruiting for a Finance Manager
We are looking for an experienced, flexible and proactive candidate to support the Senior Management Team in managing the financials of the organisation.
Date :11 June 2018
ILC-UK Commission Inquiry on Health and Wellbeing Innovation
The ILC-UK has launched a Commission Inquiry on Health and Wellbeing Innovation, supported by Audley Retirement Villages and EY.
Date :18 May 2018
However, the analysis also finds the higher the proportion of over 70s in a local population, the higher the rate of productivity growth
Date :11 May 2018
Just and ILC-UK ‘Innovating for Ageing’ project calls for submissions on problems relating to consumer vulnerability
Date :06 April 2018
Press release: Life expectancy significantly worse in deprived areas, new research finds
Life expectancy and health outcomes worsen the more deprived an area or population is, new research from Cass Business School has found.
Date :27 March 2018
